Annual report [Section 13 and 15(d), not S-K Item 405]

License, Clinical Trial and Sponsored Research Agreements (Sponsored Research and Clinical Trial Agreements) (Details)

v3.25.1
License, Clinical Trial and Sponsored Research Agreements (Sponsored Research and Clinical Trial Agreements) (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
License, Clinical Trial and Sponsored Research Agreements    
Research and development - licenses acquired $ 861,000 $ 527,000
Research and development expense 243,000 4,162,000
Nationwide children hospital | License agreements    
License, Clinical Trial and Sponsored Research Agreements    
Research and development - licenses acquired 300,000  
CSL Behring (Calimmune) | License agreements    
License, Clinical Trial and Sponsored Research Agreements    
Research and development - licenses acquired   50,000
City of Hope National Medical Center | CD123    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense   23,000
City of Hope National Medical Center | IL13Ra2    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense 427,000 1,115,000
City of Hope National Medical Center | CS1    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense   188,000
City of Hope National Medical Center | PSCA    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense   44,000
Fred Hutchinson Cancer Center - CD20    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense 312,000 1,254,000
St. Jude Children's Research Hospital - XSCID    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense (434,000) 637,000
Leiden University Medical Center - RAG1 SCID    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense 213,000 350,000
Mayo Clinic    
License, Clinical Trial and Sponsored Research Agreements    
Research and development expense $ (275,000) $ 551,000